{"id":1003855,"date":"2026-09-16T07:06:22","date_gmt":"2026-09-16T11:06:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/"},"modified":"2026-09-16T07:06:22","modified_gmt":"2026-09-16T11:06:22","slug":"alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/","title":{"rendered":"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors"},"content":{"rendered":"

<\/p>\n

Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors<\/b><\/p>\n

DUBLIN–(BUSINESS WIRE<\/a>)–Alkermes plc<\/a> (Nasdaq: ALKS) today announced the appointment of a new independent director, Anne C. Whitaker, to the company\u2019s Board of Directors (the Board). Ms. Whitaker is a seasoned biopharmaceutical executive and experienced board director who brings deep commercial and operational expertise, as well as a proven track record of driving growth and transformation across global pharmaceutical and biotechnology organizations.<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260915381220\/en\/<\/a><\/p>\n

\"Anne<\/p>\n

Anne C. Whitaker<\/p>\n<\/div>\n

\n\u201cAnne joins our Board at a defining time for Alkermes,\u201d said Blair Jackson, President and Chief Executive Officer of Alkermes. \u201cWe are building on our strong commercial performance and advancing a differentiated pipeline that we believe has the potential to address significant unmet needs in neuroscience. Anne\u2019s experience and perspectives will be valuable assets as we execute on our strategy and work to develop new medicines for patients and create long-term value for our shareholders. I look forward to working with Anne as we build on the momentum we have established across the business.\u201d<\/p>\n

\n\u201cAnne\u2019s experience as an executive and CEO across organizations of varying sizes and stages, together with her extensive service on public and private company boards, gives her a unique perspective on the key decisions that drive long-term success in our industry,\u201d said Richard Pops, Chairman of the Board of Alkermes. \u201cWe are very pleased to welcome Anne to the Alkermes Board as we continue to advance our strategic priorities.\u201d<\/p>\n

\n\u201cI am honored to join Alkermes\u2019 Board at such an exciting time in the company\u2019s evolution,\u201d said Anne Whitaker. \u201cAlkermes has built a strong foundation through scientific innovation, disciplined execution and value creation. I look forward to working alongside the Board and management team in support of Alkermes\u2019 commitment to improving outcomes for patients through innovative medicines.\u201d<\/p>\n

About Anne Whitaker
\n
<\/span><\/b>Ms. Whitaker most recently served as chief executive officer of Aerami Therapeutics, a then clinical-stage biopharmaceutical company. Prior to Aerami, she served as chief executive officer of Novoclem Therapeutics, Inc. and Synta Pharmaceuticals Corporation. Prior to those roles, Ms. Whitaker held a variety of senior commercial and executive leadership positions at Bausch Heath Companies, Inc., Sanofi S.A. and GlaxoSmithKline.<\/p>\n

\nMs. Whitaker currently serves on the boards of directors of publicly-traded companies Basilea Pharmaceutica Ltd, a commercial-stage biopharmaceutical company and ICON plc, a healthcare intelligence and clinical research organization. She also serves on the boards of directors of private companies QurAlis LLC, Bespak, Inc., Beaconcure Technologies and Trinity Partners, LLC. She previously served on the boards of directors of publicly traded companies Nykode Therapeutics, OraSure Technologies, Inc., Ergomed plc and Faron Pharmaceuticals and several other public and private life sciences companies.<\/p>\n

\nMs. Whitaker holds a B.S. in chemistry with a minor in business administration from the University of North Alabama.<\/p>\n

About Alkermes plc
\n
<\/span><\/b>Alkermes plc (Nasdaq: ALKS), a mid-cap growth and value equity, is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy. Alkermes\u2019 pipeline includes late-stage clinical candidates in development for narcolepsy and idiopathic hypersomnia, and orexin 2 receptor agonists in early clinical development for other neurological disorders, including attention-deficit hyperactivity disorder (ADHD) and fatigue associated with multiple sclerosis and Parkinson\u2019s disease. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. For more information, please visit Alkermes\u2019 website at www.alkermes.com<\/a>.<\/p>\n

Note Regarding Forward-Looking Statements
\n
<\/span><\/b>Certain statements set forth in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, but not limited to, statements concerning: the company’s expectations concerning its future financial and operating performance, business plans or prospects; and the potential therapeutic and commercial value of the company\u2019s investigational and commercial products. The company cautions that forward-looking statements are inherently uncertain. The forward-looking statements are neither promises nor guarantees and they are necessarily subject to a high degree of uncertainty and risk. Actual performance and results may differ materially from those expressed or implied in the forward-looking statements due to various risks and uncertainties, including those risks and uncertainties described under the heading \u201cRisk Factors\u201d in the company\u2019s Annual Report on Form 10-K for the year ended Dec. 31, 2025 and in subsequent filings made by the company with the U.S. Securities and Exchange Commission (SEC), which are available on the SEC\u2019s website at www.sec.gov<\/a>. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by law, the company disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260915381220\/en\/<\/a><\/span><\/p>\n

Alkermes Contacts:
\n<\/span><\/b>
For Investors: Sandy Coombs +1 781 609 6377
\n
For Media: Katie Joyce +1 781 249 8927<\/p>\n

KEYWORDS:<\/b> Europe Ireland United States North America Massachusetts<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology General Health Mental Health Health Pharmaceutical<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n\n\n\n
Photo<\/b><\/font><\/td>\n<\/tr>\n
\"Photo\"<\/td>\n<\/tr>\n
Anne C. Whitaker<\/font><\/td>\n<\/tr>\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors DUBLIN–(BUSINESS WIRE)–Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Anne C. Whitaker, to the company\u2019s Board of Directors (the Board). Ms. Whitaker is a seasoned biopharmaceutical executive and experienced board director who brings deep commercial and operational expertise, as well as a proven track record of driving growth and transformation across global pharmaceutical and biotechnology organizations. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260915381220\/en\/ Anne C. Whitaker \u201cAnne joins our Board at a defining time for Alkermes,\u201d said Blair Jackson, President and Chief Executive Officer of Alkermes. \u201cWe are building on our strong commercial performance and advancing a differentiated pipeline that … <\/p>\n

Continue reading “Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1003855","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAlkermes Announces Appointment of Anne C. Whitaker to Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors DUBLIN–(BUSINESS WIRE)–Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Anne C. Whitaker, to the company\u2019s Board of Directors (the Board). Ms. Whitaker is a seasoned biopharmaceutical executive and experienced board director who brings deep commercial and operational expertise, as well as a proven track record of driving growth and transformation across global pharmaceutical and biotechnology organizations. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260915381220\/en\/ Anne C. Whitaker \u201cAnne joins our Board at a defining time for Alkermes,\u201d said Blair Jackson, President and Chief Executive Officer of Alkermes. \u201cWe are building on our strong commercial performance and advancing a differentiated pipeline that … Continue reading "Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-16T11:06:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260915381220\/en\/2901369\/4\/Anne_Whitaker.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors\",\"datePublished\":\"2026-09-16T11:06:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/\"},\"wordCount\":882,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260915381220\\\/en\\\/2901369\\\/4\\\/Anne_Whitaker.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/\",\"name\":\"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260915381220\\\/en\\\/2901369\\\/4\\\/Anne_Whitaker.jpg\",\"datePublished\":\"2026-09-16T11:06:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260915381220\\\/en\\\/2901369\\\/4\\\/Anne_Whitaker.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260915381220\\\/en\\\/2901369\\\/4\\\/Anne_Whitaker.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors - Market Newsdesk","og_description":"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors DUBLIN–(BUSINESS WIRE)–Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Anne C. Whitaker, to the company\u2019s Board of Directors (the Board). Ms. Whitaker is a seasoned biopharmaceutical executive and experienced board director who brings deep commercial and operational expertise, as well as a proven track record of driving growth and transformation across global pharmaceutical and biotechnology organizations. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260915381220\/en\/ Anne C. Whitaker \u201cAnne joins our Board at a defining time for Alkermes,\u201d said Blair Jackson, President and Chief Executive Officer of Alkermes. \u201cWe are building on our strong commercial performance and advancing a differentiated pipeline that … Continue reading \"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-16T11:06:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260915381220\/en\/2901369\/4\/Anne_Whitaker.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors","datePublished":"2026-09-16T11:06:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/"},"wordCount":882,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260915381220\/en\/2901369\/4\/Anne_Whitaker.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/","name":"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260915381220\/en\/2901369\/4\/Anne_Whitaker.jpg","datePublished":"2026-09-16T11:06:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260915381220\/en\/2901369\/4\/Anne_Whitaker.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260915381220\/en\/2901369\/4\/Anne_Whitaker.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alkermes-announces-appointment-of-anne-c-whitaker-to-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1003855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1003855"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1003855\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1003855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1003855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1003855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}